Noven Pharmaceuticals, Inc. is recalling approximately 1,071,660 patches of Daytrana (methylphenidate transdermal system), a prescription medication used to treat ADHD. The recall was initiated because the products no longer meet the specific standards for how the protective liner is removed from the patch and other physical delivery specifications. This defect could make the patches difficult to use or affect how the medication is delivered. Consumers should contact their healthcare provider or pharmacist regarding this recall of 10 mg, 15 mg, 20 mg, and 30 mg strength patches.
The defective delivery system means the release liner may not peel away correctly from the medication patch as intended. This can lead to improper application or potential issues with the patch adhering to the skin, which may impact the consistent delivery of the medication.
Pharmaceutical product return and guidance.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.